AZFc deletions cause a significant phenotypic heterogeneity with respect to spermatogenesis; however, the reason for this is poorly understood. Recently, testis-specific protein Y-encoded 1 (TSPY1) copy number variation (CNV) was determined to be a potential genetic modifier of spermatogenesis. We performed a largescale cohort study to investigate the effect of TSPY1 CNV on spermatogenesis and to elucidate the possible contribution of TSPY1 genetic variation to the phenotypic expression of AZFc deletions. Haplogrouping of the Y-chromosome and quantification of the TSPY1 copy number were performed in 2272 Han Chinese males with different spermatogenic statuses (704 males with the b2/b4 or gr/gr deletion and 1568 nonAZFc-deleted males). Our data revealed that the TSPY1 copy number distributions were significantly different among non-AZFc-deleted males with different spermatogenic phenotypes. Lower sperm production and an elevated risk of spermatogenic failure were observed in males with fewer than 21 TSPY1 copies and in those with more than 55 copies relative to men with 21 -35 copies. Similar results were observed in males with the gr/gr deletion. These findings indicate that TSPY1 CNV affects an individual's susceptibility to spermatogenic failure by modulating the efficiency of spermatogenesis and strongly suggest that there is a significant quantity effect of the TSPY1 copy number on the phenotypic expression of the gr/gr deletion. To our knowledge, this CNV is the first independent genetic factor that has been clearly observed to influence the spermatogenic status of gr/gr deletion carriers. A combined genetic analysis of the TSPY1 copy number and the gr/gr deletion could inform the clinical counselling of infertile couples.
INTRODUCTION
The male-specific Y-chromosome contains several testisspecific genes, a subset of which is indispensable for spermatogenesis. The deletion of these genes can significantly impair spermatogenesis, resulting in male infertility. In the azoospermia factor (AZF) region on Yq11.23, deletions that remove the entire AZFa or AZFb regions are associated with Sertoli cell-only syndrome and spermatogenic arrest, primarily leading to azoospermia (1 -4) . The more common deletion of the entire AZFc region (b2/b4 deletion) is a dominant cause for severe spermatogenic failure and results in a variable semen phenotype that ranges from severe oligozoospermia to azoospermia (5 -7) . Moreover, the gr/gr deletion that involves 9 of 32 gene transcription units in the AZFc region, one of the most common mutations in the AZF region, has also been observed to be a risk factor for spermatogenic failure, although the semen phenotypes of deletion carriers vary from † The authors wish it to be known that, in their opinion, the first 2 authors should be regarded as joint First Authors. * To whom correspondence should be addressed at: Department of Medical Genetics, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Gaopeng Street, Keyuan Road 4, Chengdu 610041, People's Republic of China. Tel: +86 2885164007; Fax: +86 2885164009; Email: yangyuan@scu.edu.cn normozoospermia to azoospermia (7 -10) . The exact cause for the variable spermatogenic phenotypes that result from AZFc deletions is unclear, although the influences of genetic factors have been suggested (11, 12) .
Another highly dynamic region on the Y-chromosome is the testis-specific protein Y-encoded 1 (TSPY1) gene array (13, 14) . There are 20-40 tandem repeated units in the proximal region of Yp11.2; each of these units is 20.4 kb long and contains one copy of TSPY1 and one copy of the CYorf16 pseudogene transcription unit (15, 16) . TSPY1 copy number variation (CNV) has been investigated in several studies, and significant polymorphisms in the TSPY1 gene dosage have been observed, ranging from 18 to 47, 23 to 64, 11 to 72, and 20 to 76 copies (13, (17) (18) (19) . Moreover, the most recent study identified a difference in the mean number of TSPY1 copies among Y-chromosome haplogroups (Y-hgs) (18) . The significant variation in the TSPY1 dosage in different populations, especially within single Y-hgs, suggested an extremely high mutation rate in the TSPY1 array (13, 18) . However, the reason for the absence of men with fewer than 11 copies and more than 76 copies of TSPY1 is difficult to understand if the copy variation results from interchromatidic non-allelic homologous recombination followed by an unequal sister chromatid exchange. A possible explanation is that the nature of the selective force for the TSPY1 dosage is related to spermatogenesis. This hypothesis is supported by the observation that TSPY1 may be a proliferation factor for the mitotic division of early germ cells (20, 21) .
To date, three studies have investigated the association of TSPY1 CNV with spermatogenesis. A study of an Italian population with matching Y-hgs between the cases and the controls suggested that the low TSPY1 copy number was associated with lower sperm production (18) . In contrast, a study in a population in the Czech Republic concluded that the high TSPY1 copy number was associated with spermatogenic impairment (22) . A third study in a Dutch population did not identify any association between TSPY1 copy number and spermatogenic efficiency (19) . These contradictory results may be due to the limited sizes of the study populations, the lack of complete Y-hg matching and differences in the test methods. For this report, we performed a large-scale cohort study in which the TSPY1 copy number of each subject, classified by their Y-hg, was determined using an absolute quantification method. This study was performed to investigate the association between TSPY1 CNV and spermatogenesis in males with and without an AZFc deletion.
In the present study, Y-chromosome haplogrouping and a quantitative analysis of TSPY1 copy numbers were performed for 2272 unrelated Han Chinese males of the same geographical origin, including 216 b2/b4-deleted patients with severe oligozoospermia, cryptozoospermia or azoospermia, 162 gr/gr-deleted controls with normozoospermia, 326 spermatogenesis-impaired patients with this deletion, 698 normozoospermic controls and 870 spermatogenesis-impaired patients without AZFc deletions (Supplementary Material, Tables S1 and S2). The correlations between TSPY1 CNV, the susceptibility to spermatogenic failure and spermatogenic efficiency were investigated in the groups that did not have AZF deletions. Similar analyses were performed for AZFc-deleted males with different spermatogenic statuses to evaluate the influence of TSPY1 CNV on the spermatogenic phenotype of the AZFc deletions.
RESULTS

The influence of Y-hgs on the spermatogenic phenotype
In the present study, a total of seven Y-hgs, C, DE * , O3 * , O1 * , O2a
* , K * (xO3 * , O1 * , O2a * ) and F * (xK * ), were observed among the non-AZFc-deleted subjects. As is indicated in Figure 1 , a significant difference in the Y-hg distribution was observed between the controls and the patients with spermatogenic failure (exact test of population differentiation, a ¼ 0.05; P ¼ 0.002); this result was similar to that of our previous report (23) . Y-chromosome O3
* was the most common hg in both the patient and the control group, with similar frequencies in the two groups. In contrast, Y-chromosome K * was more prevalent in the patient group than in the control group, and the risk of a man with this hg exhibiting impaired spermatogenesis increased 1.856 times compared with those with Y-hg O3
* (x 2 test, a ′ ¼ 0.008 with Bonferroni correction; P , 0.001, OR ¼ 2.856, 95% CI: 1.634-4.991). The enrichment for hg K * in the patient group indicates that this hg is independently associated with impaired spermatogenesis. The results imply that hg-linked factors could influence the susceptibility of a patient to spermatogenic failure.
After natural log-transforming the sperm production values (24), we observed no significant associations of the Y-hgs with either the mean sperm concentration or the total sperm count in either the controls with normozoospermia or the patients with oligozoospermia (Table 1 ).
The effect of TSPY1 CNV on the spermatogenic phenotype Association of TSPY1 CNV with spermatogenesis failure in non-AZFc-deleted males Although the TSPY1 copy number was estimated using the absolute quantitative polymerase chain reaction (qPCR) with a standard curve method, the data were not adjusted using samples with known copy numbers as determined using a gold standard method, such as pulsed-field gel electrophoresis. To ensure the reliability of the quantitative data, we performed two independent qPCR analyses using the sex determining region Y (SRY) and telomerase reverse transcriptase (TERT) genes as internal controls (tests I and II, respectively; Supplementary Material, Table S3 ). A Pearson correlation test revealed that the correlation coefficient reached 0.99, suggesting a linear relationship between the data that were obtained from the two tests (P , 0.001). This linear relationship was confirmed using the regression coefficient hypothesis test (P , 0.001), and the equation was established as y ¼ 0.92 x + 2.54, in which the independent and dependent variables reflect the data from tests I and II, respectively. The observations suggest a good degree of data similarity between the two qPCR tests.
The means and ranges of the TSPY1 copy numbers for each Y-hg are given in Table 2 . In both the normozoospermia and spermatogenic failure groups, the mean TSPY1 copy numbers were significantly different among the Y-hgs (ANOVA, a ¼ 0.05; P , 0.001), which was further confirmed when the mean copy numbers were compared between hg O3 * and the other hgs. However, no significant difference in TSPY1 copy numbers for the individual Y-hgs was observed in the present study between the patients and the controls.
To investigate the distribution of the TSPY1 copy number between males with different spermatogenic statuses, we further performed an exhaustive Chi-squared Automatic Interaction Detector (CHAID) analysis of TSPY1 copy numbers in the patients and the controls using the Decision Tree add-on module in the statistical package SPSS 17.0 (SPSS Inc., Chicago, IL, USA) (25) . The results suggested that the continuous variable (TSPY1 copy number) could be divided into five ranges (≤20, 21-35, 36-39, 40-55 and ≥56 copies). These ranges could then be used to compare the distribution of the copy number between the patients and the controls. A significant difference in the distribution of TSPY1 copy number ranges was observed between the two groups ( Fig. 2A and Supplementary Material, Fig. S1A ). The data from the two independent qPCR tests indicated that the proportions of males with ≤20 or ≥56 copies of TSPY1 were significantly higher, whereas the proportion of males with 36-39 TSPY1 copies was lower among the patients than the controls (Table 3) . Relative to men who carried 21-35 copies, which the most common range of TSPY1 copy numbers in both the patients and the controls and for which a similar frequency was observed for the two groups, the risk of a man with ≤20 or ≥56 TSPY1 copies being a patient with spermatogenic failure increased more than 0.8-and 0. The distribution difference of TSPY1 copy number ranges was also observed between the controls and the patients with oligozoospermia or azoospermia (Table 3) . Due to the potential interference of hg-linked factors, we further analysed the copy number distributions within hg O3 * . The difference in the TSPY1 copy number distribution was significant between the patients and the controls within this Y-hg ( Fig. 2B and Supplementary Material, Fig. S1B ). When the men with hg O3 * were divided into five groups Figure 1 . Comparisons of the distributions of the Y-hgs between non-AZFc-deleted patients with spermatogenic failure and controls with normozoospermia. NZ, normozoospermia; OZ, oligozoospermia; CZ, cryptozoospermia; AZ, azoospermia. The significant distribution difference was observed between the groups (a ¼ 0.05, P ¼ 0.002), and the Y-hg K * was more common in patients relative to controls (a ′ ¼ 0.007, P , 0.001). based on the TSPY1 copy number (≤20, 21-35, 36-39, 40 -55 and ≥56) according to the CHAID result, the frequencies of males with ≤20 or ≥56 TSPY1 copies were significantly higher in the patients than in the controls, whereas the frequency of men with 36-39 TSPY1 copies was lower (Supplementary Material, Table S4 ). Men with ≤20 or ≥56 TSPY1 Comparisons of the distributions of the TSPY1 copy number ranges between non-AZFc-deleted patients with spermatogenic failure and controls with normozoospermia. NZ, normozoospermia; OZ, oligozoospermia; CZ, cryptozoospermia; AZ, azoospermia. The subjects with Y-hg K * were excluded from the figure. The data of the TSPY1 copy number were obtained from test I. (A) The distributions of the TSPY1 copy number ranges in the entire study population without classification by Y-hgs. The significantly higher frequencies of men with ≤20 and ≥56 copies (a ′ ¼ 0.01, both P , 0.001), and the lower frequency of men with 36-39 copies of TSPY1 (a ′ ¼ 0.01, P , 0.001) were observed in patients relative to those in controls. (B) The distributions of the TSPY1 copy number ranges in men with Y-hg O3 * . The significantly higher frequencies of men with ≤20 and ≥56 copies (a ′ ¼ 0.01, P ¼ 0.002 and 0.005, respectively), and the lower frequency of men with 36-39 copies of TSPY1 (a ′ ¼ 0.01, P ¼ 0.005) were observed in patients relative to those in controls. (C) The distributions of the TSPY1 copy number ranges in men with non-Y-hg O3 * . The significantly higher frequencies of men with ≤20 copies (a ′ ¼ 0.01, P ¼ 0.008), and the lower frequency of men with 36-39 copies of TSPY1 (a ′ ¼ 0.01, P ¼ 0.005) were observed in patients relative to those in controls. Fig. S1C ).
The correlation between TSPY1 CNV and sperm production in non-AZFc-deleted males Due to the detectable effect of TSPY1 CNV on the susceptibility to spermatogenic failure, we further analysed the correlation between TSPY1 copy number and sperm production, including sperm concentration and the total sperm count, in 898 males with the most frequent monophyletic Y-hg (O3 * ). Four hundred seventeen controls and 481 patients were included in this analysis. Using the non-parametric Spearman test, a positive correlation was identified between the TSPY1 copy number and the sperm count in all the subjects with Y-hg O3 * (sperm concentration: r coefficient ¼ 0.113, P , 0.001; total sperm count: r coefficient ¼ 0.132, P , 0.001). The correlation was more significant in the 417 controls with normozoospermia (sperm concentration: r coefficient ¼ 0.218, P , 0.001; total sperm count: r coefficient ¼ 0.241, P , 0.001). In the 481 patients with spermatogenic failure, no such correlation was observed. The above positive correlations were visualized using scatter plots of TSPY1 copy number versus sperm production (Fig. 3) .
Furthermore, we compared the distributions of sperm production ranges between males with 21-55 TSPY1 copies and either ≤20 or ≥56 copies in the normozoospermic group with Y-hg O3 * . As is shown in Figure 4 and Supplementary Material, Figure S2 , significant differences were observed in the distributions of sperm concentration and the total sperm count (P , 0.001 for both), in that the frequencies of men with sperm concentrations of ≥50 × 10 6 /ml and total sperm counts of ≥150 × 10 6 were significantly lower in the subgroups that were composed of men with either ≤20 or ≥56 TSPY1 copies compared with the subgroup of men with 21-55 copies (x 2 test, a ¼ 0.05; sperm concentration: both P c ¼ 0.002; total sperm count: P c , 0.001 and 0.001 following Bonferroni correction, respectively). This difference was not observed in the hg O3
* group with spermatogenic failure. The latter result may be due to the presence of unknown factors that negatively affect sperm production in addition to TSPY1 CNV, which may impair spermatogenic function in this group. In this case, the contribution of TSPY1 CNV to sperm production would be limited compared with the effects of other factors. Thus, a significant difference was not observed using the current number of subjects, although the frequency of men with a sperm concentration of ≥5 × 10 6 /ml or a total sperm count of ≥15 × 10 6 in the subgroup with 21-55 TSPY1 copies was higher than what was observed for those with either ≥20 or ≤56 copies. The TSPY1 copy number ranges were distinguished according to the suggestion of the exhaustive CHAID analysis using the decision tree method. The exact test of population differentiation for comparing the distributions of TSPY1 copy number ranges between groups with normozoospermia and spermatogenic failure.
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More specifically, we compared sperm production between men harbouring 21-55 copies and either ≤20 or ≥56 copies of TSPY1 within the controls and the patients with oligozoospermia. The results indicated that sperm production was significantly lower in men with ≤20 or ≥56 copies of TSPY1 than in men with 21-55 copies of TSPY1 across the entire population. The difference in sperm production between men with ≥56 copies and 21-55 copies of TSPY1 with Y-hg O3 * did not reach significance, potentially due to the limited sample size (Table 4 ). These results suggested a possible interpretation for the lack of correlation between the TSPY1 copy number and the sperm count in the patients with spermatogenic failure, namely, the presence of a large proportion of men carrying ≥56 TSPY1 copies with low sperm production in the patient group. This interpretation was supported by the observation that the r coefficient was .0.2 (P , 0.001) in the patients with ≤55 TSPY1 copies.
An interesting result of the present study is the negative effect of excess TSPY1 copies on spermatogenic efficiency. We further analysed the correlation between the TSPY1 copy number and the total sperm count in the subjects with ≥56 TSPY1 copies, including 33 men with normozoospermia and 76 men with spermatogenic failure; no significant correlation was observed in the two groups (normozoospermic group: r coefficient ¼ 20.108, P ¼ 0.479; spermatogenesis-impaired group: r coefficient ¼ 20.087, P ¼ 0.722). Moreover, the highest TSPY1 copy number among those with the Ychromosome C, DE * , O3 * , O1 * and O2a * haplogroups in men with normozoospermia was 95, 65, 76, 63 and 72, respectively. The highest TSPY1 copy number in men with spermatogenic failure was 63, 67, 101, 90 and 76, respectively. The means of the total sperm count were (59.3 + 19.5) × 10 6 and (4.1 + 2.2) × 10 6 in the carriers of high TSPY1 copy numbers with normozoospermia and spermatogenic failure. This result suggests that excess TSPY1 copies per se do not lead to spermatogenic failure; however, the carriers may be prone to spermatogenic failure when other factors that negatively affect spermatogenesis are present.
The effect of TSPY1 CNV on the phenotypic expression of the AZFc deletions Copy deletion subtypes of gr/gr deletion and sperm production We measured the TSPY1 copy number and the Y-hg type in men with gr/gr deletions with different spermatogenic statuses. The copy deletion subtyping of deleted in azoospermia (DAZ) and chromodomain protein, Y-linked, 1 (CDY1) gene families was performed in these gr/gr deletion carriers. A total of four copy deletion subtypes within six Y-hgs, including C, DE * , O3 * , O1 * , O2a * and Q1, were observed in 478 males with gr/gr deletions. The numbers and proportions of the copy deletion subtypes in the controls and the patients with spermatogenesis failure are indicated in Supplementary Material, Table S5 . In a previous study, we suggested that the DAZ1/ DAZ2 + CDY1a or DAZ1/DAZ2 + CDY1b deletion is a risk factor for impaired spermatogenesis and that the DAZ3/ * groups with 21-35 copies and ≤20 or ≥56 copies of TSPY1. The data of the TSPY1 copy number were obtained from test I. NZ, normozoospermia; OZ, oligozoospermia; CZ, cryptozoospermia; AZ, azoospermia. (A1) The distributions of the sperm concentration ranges in men with normozoospermia. The significantly higher frequencies of men with the sperm concentration of ≥50 × 10 6 /ml were observed in the group with 21-35 TSPY1 copies than that in the group with ≤20 or ≥56 copies of TSPY1 (a ¼ 0.05, both P c ¼ 0.002). (A2) The distributions of the total sperm count ranges in men with normozoospermia. The significantly higher frequencies of men with the total sperm count of ≥150 × 10 6 were observed in the group with 21-35 TSPY1copies than that in the group with ≤20 or ≥56 copies of TSPY1 (a ¼ 0.05, P c , 0.001 and 0.001, respectively). (B1) The distributions of the sperm concentration ranges in men with spermatogenic failure. No difference in the distributions of the sperm concentration ranges among men with difference TSPY1copies was observed. (B2) The distributions of the total sperm count ranges in men with spermatogenic failure. No difference in the distributions of the total sperm count ranges among men with difference TSPY1 copies was observed. Table 4 . Comparisons of the natural log values of the sperm production (mean + SD) among different ranges of the TSPY1 copy number in the normozoospermia and the oligozoospermia group without the AZFc deletion TSPY1 copy number ranges
Total sperm number
Total sperm number DAZ4 + CDY1b deletion may be a constitutively structural polymorphism of Y-hg Q1 in the population. However, there was lack of the sperm production data for the deletion carriers in this previous report (26) . In the present study, we compared the mean sperm concentration and the total sperm count among men with gr/gr deletions with different copy deletion subtypes within normozoospermic males and patients with oligozoospermia. Significantly lower sperm concentrations and total sperm counts were observed in the DAZ1/DAZ2 + CDY1a, DAZ1/DAZ2 + CDY1b and DAZ3/DAZ4 + CDY1a deletion carriers relative to non-AZFc deleted men within the normozoospermic group (Supplementary Material, Table S6 ). Further comparisons within carriers with ≤20 or ≥56 copies and 21-55 copies of TSPY1 (with the former group possibly being at risk and the latter possibly having the optimal copy number range for spermatogenesis) were performed; a significant difference was observed. The results strongly support the hypothesis that the three copy deletion subtypes of gr/gr deletions have a negative effect on spermatogenesis. No difference in sperm production was observed within the gr/gr-deleted group with oligozoospermia. This result is potentially due to stratified interference resulting from the presence of other unknown negative factors for spermatogenesis.
In the present study, all the 113 carriers of the DAZ3/ DAZ4 + CDY1b deletion were observed to harbour hg Q1. As is shown in Supplementary Material, Table S6 , sperm production within the normozoospermic group of the deletion carriers was similar to that of men without the AZFc deletion and was significantly higher than those of men with the other three deletions. These results suggest that the effect of the DAZ3/ DAZ4 + CDY1b deletion on spermatogenesis of men with hg Q1 is more likely to be neutral. To further investigate whether the TSPY1 copy number in hg Q1 is a dominant factor in influencing the effect of the DAZ3/DAZ4 + CDY1b deletion on spermatogenesis, we compared the distribution of TSPY1 copy number ranges between Y-hg Q1 and the other gr/gr-deleted hgs; no significant difference was observed (Supplementary Material, Fig. S3 ; exact test of population differentiation, a ¼ 0.05; test I, P ¼ 0.686; test II, P ¼ 0.623). This result indicates that there is no significant enrichment of Y-chromosomes with moderate TSPY1 copy numbers (21 -55 copies) in men with hg Q1. This result suggests that other Y-hg Q1-linked genetic factors rather than the TSPY1 copy number dominantly affect the consequence of the deletion on spermatogenesis. Alternatively, the copy deletion subtype of the gr/gr deletion may be a structural polymorphism of the Y-chromosome.
The influence of TSPY1 CNV on the spermatogenic phenotype of AZFc-deleted males In the present study, no significant differences in the mean TSPY1 copy numbers were observed in any Y-hgs between gr/gr deletion carriers with spermatogenic failure and normozoospermia (Supplementary Material, Table S7 ). However, we noted a significant difference in the distribution of the TSPY1 copy number between the two groups ( Fig. 5A and Supplementary Material, Fig. S4A ), indicating that the frequency of men with ≤20 TSPY1 copies was significantly higher in gr/ gr-deleted patients with impaired spermatogenesis. Moreover, men with 36 -39 TSPY1 copies were more common among the deletion carriers with normozoospermia (Table 5) . Notably, in groups with the gr/gr deletion, the men with ≤20 TSPY1 copies had a much higher risk of spermatogenic failure (x 2 test, a ′ ¼ 0.013; test I, P ¼ 0.012, OR ¼ 3.676, 95% CI: 1.252 -10.788; test II, P ¼ 0.012, OR ¼ 3.293, 95% CI: 1.240 -8.747). Although the frequency of men with ≥56 copies of TSPY1 was higher in patients with the gr/gr deletion than in the deletion carriers with normozoospermia, this difference did not reach significance, potentially due to the less number of subjects. Moreover, we observed similar distributions of the TSPY1 copy number in b2/b4-deleted patients with severe impaired-spermatogenesis (Fig. 5B and Supplementary Material, Fig. S4B ). Furthermore, we observed that sperm production, including sperm concentration and the total sperm number, was significantly lower in the men with gr/gr deletions with ≤20 copies of TSPY1 compared with those with 21 -55 copies for both patients and normozoospermic men (Fig. 6, Supplementary Material, Fig. S5 and Table S8 ).
To obtain more convincing evidence for the effect of TSPY1 CNV on the spermatogenic phenotype of the gr/gr deletion, we further investigated the potential variation of the TSPY1 copy number when the multicopy gene was transmitted from one generation to the next. First, the TSPY1 copy number was measured in 101 pairs of fathers and sons with unknown AZF structure; a difference in the TSPY1 copy number was observed between 81.2% (82/101) of fathers and paired sons. As is shown in Supplementary Material, Table S9 , the variation range of the copy number was 9.2 + 9.5 (mean + SD) in test I and 9.1 + 9.4 in test II. No significant correlation between the TSPY1 copy number range of the fathers and the variation rate was observed for these subjects (Supplementary Material, Table S10 ). In view of the high variation rate of the TSPY1 copy dosage, we then measured the copy number in 71 pairs of gr/gr-deleted fathers and their son after excluding the subjects with Y-hg Q1 (Supplementary Material, Tables S11 and S12). Although the shift of the TSPY1 copy number from the optimal (21 -55 TSPY1 copies) to the risk range (≤20 or ≥56 copies) and the opposite shift both were observed in 22 father -son pairs in whom the sons were normozoospermic and 49 father -son pairs in whom the sons suffered from spermatogenic failure, the result revealed that the frequency of men with the risk copy number of TSPY1 (≤20 or ≥56 copies) was significantly higher in sons with spermatogenesis failure relative to their fertile fathers, indicating that the contraction or expansion of the TSPY1 copy number into the risk ranges may have had a negative effect on spermatogenesis of the sons (Table 6 ). The findings strongly support the hypothesis that TSPY1 CNV is an important genetic factor that influences the phenotypic expression of the gr/gr deletion.
The interaction of Y-hgs and TSPY1 CNV on the spermatogenic phenotype
Due to the potential influence of a Y-hg-linked factor and the TSPY1 copy number on spermatogenesis, the interaction of the two factors on the spermatogenic phenotype was further analysed (Table 7 and Supplementary Material, Table S13 ). We Human Molecular Genetics, 2013, Vol. 22, No. 8 1687 compared the sperm concentration and the total sperm count among the subjects with the different Y-hgs who exhibited the optimum TSPY1 copy number range and among the subjects with the different Y-hgs who exhibited the risk TSPY1 copy number range within non-AZFc-deleted men with normozoospermia and oligozoospermia. No significant difference was observed in the sperm production of men with different Y-hgs in either of these TSPY1 copy number ranges. A similar result was obtained for a comparison within men with gr/gr deletions with normozoospermia and oligozoospermia. Therefore, in the present study, there was no evidence for a compound effect of a Y-hg-linked factor and the TSPY1 copy The P values showing significant difference were keyed in boldface. The gr/gr deletions included three subtypes involving DAZ1/DAZ2 + CDY1a, DAZ1/DAZ2 + CDY1b and DAZ3/DAZ4 + CDY1a, respectively. The subjects with Y-hg Q1 including 113 carriers of the gr/gr-DAZ3/DAZ4 + CDY1b deletion and 11 carriers of the b2/b4 deletion were excluded from the table. NZ, normozoospermia; OZ, oligozoospermia; CZ, cryptozoospermia; AZ, azoospermia. a x 2 -test significant level was calculated with the formula a ′ ¼ a/5 ¼ 0.01 according to the Bonferroni method for comparing the proportion of certain TSPY1 copy number range between gr/gr-deleted groups with normozoospermia and spermatogenic failure. b x 2 -test significant level was calculated with the formula a ′ ¼ a/5 ¼ 0.01 according to the Bonferroni method for comparing the proportion of certain TSPY1 copy number range between b2/b4-deleted groups with oligozoospermia and azoospermia.
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The exact test of population differentiation for comparing the distributions of TSPY1 copy numbers between groups with normozoospermia and spermatogenic failure. number on the spermatogenic phenotype. This result is potentially due to the limited number of subjects in each Y-hg.
DISCUSSION
The Y-chromosome has a high mutation rate, primarily due to the presence of three dynamic regions. These regions include the euchromatic TSPY1 array, AZFc and the heterochromatic DYZ1 array (13, 14) . The common structural mutations of the AZFc region, including the b2/b4 and gr/gr deletions, and their correlation with spermatogenesis have been comprehensively researched in different ethnic and geographic populations (11, (26) (27) (28) (29) (30) (31) (32) (33) . However, why the spermatogenic phenotype of the deletion carrier varies from normozoospermia to azoospermia, even among men with the same deletion subtype, is unknown. Therefore, for clinical purposes, it is difficult to link the contribution of the deletions to spermatogenic failure. More efforts should be made to investigate the influence of other sex chromosome or autosomal loci in the modulation of the phenotypic expression of such deletions.
The TSPY1 array, which is another dynamic region on the Y-chromosome, has received increasing attention due to its potential role in spermatogenesis. The product of the TSPY1 gene is a member of a protein superfamily of activating factors that are involved in replication. Full-length TSPY1 is expressed predominantly in the spermatogonia of the testis, suggesting that this protein may act as a proliferation factor that regulates male germ cell development during the mitotic division stage of spermatogenesis (20, 34, 35) . The TSPY1 copy number varies significantly in males (13, (17) (18) (19) . A total of three studies regarding the association of TSPY1 Figure 6 . Comparisons of sperm production in the different TSPY1 copy number ranges in men with the gr/gr deletion. The subjects with Y-hg Q1 were excluded from the figure. The data of the TSPY1 copy number were obtained from test I. The asterisks indicate the significant difference in sperm production. The significant level of statistical analysis is 0.025 after the Bonferroni correction. (A1) A significant difference in sperm concentration between normozoospermic men with ≤20 copies and 21-55 copies of TSPY1 was observed. (A2) A significant difference in the total sperm count between normozoospermic men with ≤20 copies and 21-55 copies of TSPY1 was observed. (B1) A significant difference in the sperm concentration between spermatogenesis-impaired men with ≤20 copies and 21-55 copies of TSPY1 was observed. (B2) A significant difference in the total sperm count was observed between spermatogenesis-impaired men with ≤20 copies and 21-55 copies of TSPY1.
CNV with spermatogenesis were conducted, two of which suggested that TSPY1 CNV had a potential effect on sperm production and/or the susceptibility to spermatogenic failure (18, 19, 22) . In the present study, we investigated the effect of TSPY1 CNV on the phenotypic expression of the deletions to better understand the role of Y-linked genetic factors in spermatogenic failure.
Due to the contradictory results regarding the correlation between TSPY1 CNV and spermatogenesis in earlier studies (18, 19, 22) , we first investigated this question in a large number of non-AZFc-deleted subjects. We obtained additional, comprehensive evidence that strongly suggests that TSPY1 CNV plays a significant role in the regulation of spermatogenic efficiency, thereby influencing the susceptibility to spermatogenic failure. Our results indicated that there was a significant difference in the TSPY1 copy number distribution between those with normozoospermia and those with spermatogenic failure. This difference primarily resulted from significantly larger proportions of men with either ≤20 or ≥56 copies of TSPY1 in the patient group than in the control group. To exclude the interference of other, unknown hg-linked factors that potentially influence spermatogenesis, we compared the TSPY1 copy number distribution of both patients and controls within the most common Y-hg (O3 * ) and observed similar results. These novel findings indicate that not only males with few copies of TSPY1 but also those with excessive copies of TSPY1 have a higher risk of spermatogenic failure compared with those with 21-35 copies of TSPY1, which was the most frequent copy range for both patients and controls in the study population. This result strongly suggests that TSPY1 CNV affects spermatogenic status and the susceptibility to spermatogenic failure. We also compared sperm production among males with ≤20, ≥56 and 21-55 TSPY1 copies for both the entire population and those with hg O3
* . The results indicated that, for both the patient and the control group, men with few or excessive TSPY1 copy numbers had significantly lower sperm production than did men with a moderate number of TSPY1 copies. This observation suggests that TSPY1 CNV plays a significant role in the regulation of spermatogenic efficiency and that the correlation between the TSPY1 copy number and sperm production may be more complicated than a simple positive correlation. Our results have certain differences from those of previous report (18) , especially regarding the distribution of high copy numbers of TSPY1. It is possible that such differences result from the lack of validation of the TSPY1 copy number assay against the gold standard method, which was not used in the present study. This difference in methodology partially limits the direct comparison of the present results with previous reports. Other potential causes for the discrepancies include the relatively limited number of subjects in the previous study, the different inclusion criteria for the subjects and the genetic diversity between the two populations.
Based on the findings of TSPY1 function studies, TSPY1 overexpression promotes cell cycle progression at the G2/M transition by modulating cyclin B-CDK1 activity (34, 36 ). It appears to be a reasonable hypothesis that more TSPY1 copies may increase spermatogenesis efficiency by positively affecting germ cell proliferation, further leading to a significantly lower susceptibility to spermatogenic failure. According to Giachini et al. (18) , we found a positive correlation between the TSPY1 copy number and sperm production. However, the comparison of the three TSPY1 categories (≤20, 21-55 and ≥56) identified that excessive copies of TSPY1 increase the risk for low sperm production and impaired spermatogenesis. Although the latter is perplexing, certain cancer-related studies have offered certain clues in this respect, reporting that a higher copy number or higher TSPY1 expression was observed in normal tissue relative to cancer cells and in highly differentiated tumours relative to undifferentiated tumours. These results therefore imply that more TSPY1 protein may not be always with more active cell division and proliferation (37, 38) . Due to the limited understanding of TSPY1 function in spermatogenesis, it is rather difficult to speculate as to the potential mechanism for the negative effect of high copy numbers of this gene on spermatogenic efficiency. However, a similar result has also been identified for other Y-linked genes that are involved in spermatogenesis. For example, the AZFc duplication, which doubles the number of AZFc genes, was suggested to be disadvantageous for spermatogenesis in certain populations, whereas this effect was not observed in other populations (39) (40) (41) . To better understand the effect of TSPY1 copy variation on spermatogenic efficiency, it will be essential to investigate the correlation between TSPY1 expression in testis tissue as well as the TSPY1 copy number. The P values showing significant difference were keyed in boldface. The gr/gr-DAZ3/DAZ4 + CDY1b-deleted subjects with Y-hg Q1 including 9 with normozoospermia and 13 with spermatogenesis failure were excluded from the table. NZ, normozoospermia; OZ, oligozoospermia; CZ, cryptozoospermia; AZ, azoospermia.
a
The potential risk ranges of the TSPY1 copy number for spermatogenesis failure. b The potential moderate range of the TSPY1 copy number for spermatogenesis. 1690 Human Molecular Genetics, 2013, Vol. 22, No. 8
After obtaining evidence for the negative effect of three gr/gr copy deletion subtypes on spermatogenesis in the population, we further analysed the influence of the TSPY1 copy number on the phenotypes that were associated with the gr/gr deletions. Our results provide persuasive evidence to suggest that TSPY1 CNV is an important genetic factor that significantly affects spermatogenic status and sperm production in men with the gr/gr deletion. This evidence included the following three points. First, the TSPY1 copy number distribution was significantly different between men with gr/gr deletions with spermatogenic failure and those with normozoospermia. More importantly, males with gr/gr deletions with ≤20 TSPY1 copies were at a higher risk for spermatogenic failure than were men with 21 -35 copies. Second, for both patients and controls with the gr/gr deletion, sperm production, including sperm concentration and the total sperm number, was significantly lower in men with ≤20 TSPY1 copies than in men with 21-55 TSPY1 copies. Third, not only was significant TSPY1 copy variation identified between fathers and paired sons, but among males with gr/gr deletions and spermatogenic failure, the frequency of those with TSPY1 copy numbers within the potential risk ranges (≤20 or ≥56 copies) was significantly higher relative to their fathers. The enrichment of TSPY1 copy numbers in the "at risk" range among spermatogenesis-impaired sons due to the contraction or expansion of the TSPY1 copy number offers more convincing evidence for the effect of TSPY1 copy number on the phenotype of gr/gr deletions. Although the common gr/gr deletion was identified 10 years ago, we still know very little regarding the genetic factors that potentially influence the phenotypic expression of this deletion. In the present study, we obtained several important pieces of evidence that suggest a significant contribution from TSPY1 CNV to the spermatogenic phenotype of men with the gr/gr deletion. It is likely that this contribution involves the functions of the TSPY1 and AZFc genes. TSPY1 is expressed predominantly in spermatogonia and is a potential proliferation factor for the mitotic division of early germ cells. Compared with the effect of a moderate number of TSPY1 copies on mitotic cells, a low or excessively high number of TSPY1 copies may weaken this process, producing fewer primary spermatocytes and thereby decreasing sperm production. This effect may increase the risk for spermatogenic failure in contexts where the individual is affected by other genetic or environmental factors that are negative for spermatogenesis, such as the gr/gr deletion. The DAZ gene in the AZFc region is regarded as the most important candidate responsible for spermatogenic failure, and the protein product of the gene is suggested to promote the later stages of meiosis and the development of haploid gametes (42) . In men with the gr/gr deletion, two copies of DAZ are always lost. This deletion may affect meiosis to a certain extent, increasing the risk for spermatogenic impairment. Therefore, in men with gr/gr deletions with low or excessive TSPY1 copy numbers, low mitotic efficiency together with the consequent limited meiosis may significantly increase the risk of spermatogenic failure compared with those with moderate TSPY1 copy numbers. In the present study, we did not observe any evidence for an effect of TSPY1 CNV on the degree of the severity of the spermatogenic impairment in men with the b2/b4 deletion. This result (7) 4.77 + 0.42 (7) 3. In association studies of Y-linked genetic factors, stratification bias may be significant if the high baseline mutation rate for the Y-chromosome is not taken into account. This bias would be due to the different genetic constitutes among Ychromosomes and the potential effect of certain mutation loci on the Y-linked phenotypes being examined. In the present study, similar to two previous reports (17, 18) , we also observed the significant differences in the TSPY1 copy number between Y-hgs, strongly supporting the idea that Y-hg matching is an important prerequisite in case -control studies of Y-linked genetic factors to maximally decrease stratification bias.
In conclusion, this large-scale cohort study provides additional and more comprehensive evidence for the association of the TSPY1 copy number with sperm production and susceptibility to spermatogenic failure. These results also support the hypothesis that TSPY1 CNV plays an important role in the regulation of spermatogenic efficiency. TSPY1 CNV was correlated with susceptibility to spermatogenic failure in men with the gr/gr deletion, suggesting that the TSPY1 copy number is an independent genetic factor that significantly affects the phenotypic expression of the gr/gr deletion in spermatogenesis. A reconsideration of the effects of Y-linked structural mutations, including the gr/gr deletion, on spermatogenesis may be required, in part by combining this information with the TSPY1 copy number. Such an analysis would allow for a more accurate estimation of the potential clinical consequences of these mutations in preventing genetic defect transmission and genetic counselling. We believe that these findings are important for the targeted investigation of other potential functional variations and their effects on spermatogenesis. Together, these studies will aid in the better understanding of spermatogenic pathologies. Table S1 . Semen analysis was performed for all of the men at least three times, and their spermatogenic phenotypes were determined according to the latest reference criteria of the World Health Organization (43) . None of the subjects carried a complete AZFa or AZFb deletion or other chromosomal abnormalities according to the results of AZFa/b-specific sequence-tagged sites (STSs) and karyotype analysis (44) . None of the non-AZFc-deleted subjects carried partial AZFc duplications according to the results of DAZ and CDY1 dosage analysis (40) . Other possible causes resulting in spermatogenic failure, such as obstruction or absence of the vas deferens, orchitis, cryptorchidism and varicocele, were also excluded. Moreover, subjects with a deletion of AMELY (amelogenin, Y-linked) according to the absence of sY70 and sY276 in STS-PCR analysis were excluded (18) . In addition, 101 pairs of fathers and sons with unknown AZFc structure and 93 gr/gr-deleted fathers of the subjects in the second group above were recruited for investigating the variation of the TSPY1 copy number from one generation to the next. This study was approved by the Institutional Ethical Review Board of Sichuan University, and signed informed consent was obtained from all of the study subjects.
MATERIALS AND METHODS
Study population
Detection of AZFc deletions
Peripheral blood samples from 216 men with the b2/b4 deletion and 488 men with the gr/gr deletion were collected from four medical units of Sichuan province, and genomic DNA was extracted from lymphocytes using DNA isolation kits (TaKaRa Co., Ostu, Japan). Due to the possible presence of the rare AZFb + c deletion type, which cannot be distinguished from the b2/b4 deletion by the sY254 and sY255 analysis (4,41), we detected the AZFc structures in the potential b2/b4-deleted samples with additional STSs, including sY142, sY1258, sY1161 and sY1197, and performed further gene dosage analyses of DAZ and CDY1 using capillary electrophoresis (26, 33, 45) . The b2/b4 deletions in all 216 samples were confirmed based on the presence of the four STSs and the absence of DAZ and CDY1.
To remove any samples with a false gr/gr deletion and to obtain more information regarding their copy deletions, gene copy and dosage analyses for DAZ and CDY1 were performed. Four single-nucleotide variant (SNV) loci (sY587, sY581, DAZ-SNV II and CDY1-7750) were amplified, and their PCR products were digested with the restriction enzymes DraI, Sau3A, MboI and PvuII, respectively, to detect deletions of DAZ and CDY1 (33, (46) (47) (48) (49) . In addition, quantitative analyses of the DAZ and CDY1 copy numbers were performed by co-amplifying DAZ/DAZL and CDY1/CDY2 using multiplex PCR and comparing the DAZ and CDY1 peak areas with those of DAZL and CDY2 via a PCR-capillary electrophoresis method (26, 33) . As a result, a total of 10 gr/gr deletions were identified as false. The remaining 478 samples were confirmed as carrying the gr/gr deletion with four different subtypes removing DAZ1/DAZ2 + CDY1a, DAZ1/DAZ2 + CDY1b, DAZ3/DAZ4 + CDY1a and DAZ3/DAZ4 + CDY1b, respectively (Supplementary Material, Table S3 ).
Analysis of the Y-chromosome haplogroup
A difference in mean TSPY1 copy numbers among the Y-hgs was observed in the most recent study (18) . To avoid stratification bias in the comparisons of the mean TSPY1 copy numbers between the cases and controls, Y-chromosome haplogrouping of all of the subjects was conducted to allow these comparisons to be performed in the background of a single Y lineage. In this study, a total of 10 highly informative polymorphic loci for East Asians were used to define the Y-chromosome haplotypes (50, 51) . Five of the 10 singlenucleotide polymorphisms (SNPs; M130, M122, M119, M120 and LLY22g) were detected by the direct DNA sequencing of PCR products on an ABI377A DNA sequencer (Applied Biosystems, Foster City, USA) using the Dye Terminator method. Other four SNPs including M89 (NlaIII), M9 (BamHI), M95 (Hin6I) and M45 (FspBI) were detected with PCR restriction fragment length polymorphism analysis. The M1 PCR product was separated by electrophoresis using a 3% agarose gel and was visualized using ethidium bromide staining. Following this procedure, a total of 10 Y-hgs could be distinguished, including C, DE * , F * (xK * ), O3 * , O1 * , O2a * , N * , Q1, P * (xQ1) and K * (xO3 * , O1 * , O2a * , N * , P * ). The primer sequences have been previously described in the literature (52) , with the exception of the sequence for LLY22g, which was provided by Dr C Tyler-Smith (Wellcome Trust Sanger Institute, Cambridge, UK).
Estimation of the TSPY1 copy number TSPY1 copy numbers were determined using a TaqMan probebased qPCR assay. In the analysis, SRY and TERT were used as internal controls in tests I and II, respectively. Their primers and probes were designed using AlleleID 6.0 (PREMIER Biosoft, Palo Alto, CA, USA) to perform two independent co-amplifications of TSPY1/SRY and TSPY1/TERT (Supplementary Material, Table S2 ). The specificity of the PCR primer sets was confirmed with a BLAST search of the NCBI database (http://blast.ncbi.nlm.nih.gov/). No SNVs have been identified or reported in these amplicon sequences (http://www.ncbi.nlm.nih.gov/snp/).
The PCR products for TSPY1, SRY and TERT were cloned into TaKaRa PMD20-T vectors separately, and plasmid DNA was extracted from the clones using a Plasmid Mini Kit (OMEGA, Norcross, USA). After verifying the insertion fragments by DNA sequencing of the plasmid DNA, the DNA concentrations were quantified using the Quant-iT TM dsDNA Broad-Range Assay Kit with a Qubitw 2.0 Fluorometer (Invitrogen, Carlsbad, USA). The copy numbers of the plasmids were determined by the ratios of the plasmid DNA concentrations to the total molecular weight of the plasmid and amplicon sequences. The plasmid DNA was then diluted in quantities ranging from 10 3 to 10 7 amplicon copies per microlitre to generate standard curves.
Absolute quantitation of TSPY1 copy numbers was performed with two independent tests, using SRY and TERT as internal controls. The qPCRs were performed on an ABI 7900HT Fast Real-Time PCR System (Applied Biosystems) in a total volume of 10 ml/well. Each reaction contained the following: 10-20 ng of genomic DNA; 3.5 mM MgCl 2 ; 200 mM dATP, dCTP and dGTP; 400 mM dUTP; 200 nM probe; 300 nM of each primer; 0.01 U/ml of uracil Nglycosylase and 0.025 U/ml of AmpliTaq Gold DNA polymerase. The PCR parameters were at 508C for 2 min and at 948C for 10 min, followed by 40 cycles at 948C for 15 s and 608C for 55 s. Fluorescence was detected after each cycle.
A 5-log dilution series of the plasmids containing the amplicons was used to calculate the primer efficiencies [E ¼ 10 (21/slope) 2 1] and the linearity (R 2 ) between the log copy number and the C t value after generating the standard curves. The qPCRs were performed three times per sample in the same run. The outcomes from runs with efficiencies between 90 and 110%, R 2 values of no less than 0.99 and standard deviations of no more than 0.2 for the three replicates were accepted. Repeated testing was performed in the samples that did not meet these criteria. The TSPY1 copy number for each sample was estimated relative to the ratio of the number of TSPY1 copies to the SRY copy number and to the ratio of the number of TSPY1 copies to half the TERT copy number in two tests.
Statistical analyses
The TSPY1 copy number ranges were distinguished using (exhaustive) CHAID analysis in Decision Tree add-on module with the statistical package SPSS 17.0 (SPSS Inc.). The comparisons of the Y-hg and TSPY1 copy number range distributions between the groups were performed using an exact test of population differentiation with Arlequin ver.3.11 (53, 54) . Other statistical analyses were performed using the statistical package SPSS 17.0. The x 2 test was used to compare the individual Y haplogroup distributions and the frequencies of the individual TSPY1 copy number ranges between the patient and control groups. The sperm concentration and total sperm count data were transformed to natural log values to pass a Shapiro -Wilk test of normality for the comparison between different Y-hgs or TSPY1 copy number ranges using an ANOVA approach or Student's t-test (24) . Values of P , 0.05 were regarded as statistically significant in the tests, except for multiple tests with the correction of the degree of significance using the Bonferroni method (55) .
